Literature DB >> 30191135

Copper oxide nanoparticles induces oxidative stress and liver toxicity in rats following oral exposure.

Rama Narsimha Reddy Anreddy1.   

Abstract

The present study aimed to evaluate the effect of Copper Oxide (CuO) Nanoparticles (NP) on liver following oral exposure in rats. A total of 18 male wister rats were used in the experiments including a control group (6 rats). NP were given to the rats with a doses (5, 50 mg/kg b.w./day) via oral gavage and a control group (received only 200 μl PBS). The treatment was continued for 14 days. The supernatants of rat Liver tissue homogenates were used to analyze for glutathione levels (GSH), Catalase, superoxide dismutase (SOD), the extent of lipid peroxidation products (Malondialdehyde, MDA). Oral administration of NP to rats caused a significant (P < 0.05) dose dependent alterations in antioxidant enzyme activities. Data results clearly showed the significant decrease (p < 0.05) in GSH, Catalase (CAT) and SOD activity, whereas the lipid peroxidation product (MDA) levels were increased (p < 0.05). In conclusion, oral exposure of CuO nanoparticles to rats causes significant toxicity to the liver and it might be due to oxidative stress.

Entities:  

Keywords:  CAT; Copper oxide nanoparticles; CuO; GSH; Liver toxicity; MDA; NP; SOD

Year:  2018        PMID: 30191135      PMCID: PMC6125791          DOI: 10.1016/j.toxrep.2018.08.022

Source DB:  PubMed          Journal:  Toxicol Rep        ISSN: 2214-7500


Introduction

Nanoparticles (NP) with <100 nm size, are widely used nanotechnology [1,2]. Metal-oxide NP contain heavy metal ions and other organic and inorganic groups which make them unique in their functional groups, electronic properties, shape, surface structure and aggregation behavior. Because of these particular characteristics make the nanoparticles suitable for various applications in modern industries [3]. However, widespread use of nanomaterials may lead to environmental contamination and human exposure by inhalation, dermal and oral routes, raising concerns about their potential toxicity [4]. The extreme usage of these NP brings challenges to the environment and to humans. With sizes smaller than cellular organelles, nanoparticles can easily penetrate through basic biological structures [5]. Administration routes (oral, inhalation, subcutaneous, injection etc.) of NPs are also known to have significant effects on their toxicities in mammals [6]. Copper oxide nanoparticles (CuO NPs) have attracted attention and used in industrial, commercial fields like medicine, engineering for their photovoltaic and photoconductive properties [7]. Copper oxide is a semiconductor metal with unique optical, electrical and magnetic properties and it has been used for various applications, such as the development of supercapacitors, near-infrared filters, in magnetic storage media, sensors, catalysis, semiconductors, etc. [7]. Particularly, CuO NPs useful in the pharmaceutical industry especially in the production of anti-microbial fabric treatments or prevention of infections caused by E.coli and methicillin-resistant S.aureus. [8]. In this study, we aimed at investigating the effects of oral exposure of CuO NP on the antioxidant enzyme activities in the liver in Wistar rats.

Materials and methods

Nanoparticles

CuO NPs (size < 50 nm, surface area 29 m2/g, crystalline shape, diameter <50 nm, length <50 nm) purchased from Sigma Aldrich, USA. Suspension of CuO NPs was prepared using Phosphate Buffer Saline (PBS) and subsequently sonicated and mixed vigorously with a sonicator (20 min).

Animals and treatment

Male wistar albino rats (Mahaveer Enterprises, Hyderabad, India) of 8 weeks old at study start (180–200 g) were selected. A total of 18 rats were used in the experiments as each experimental group consisted of 6 rats, including a control group (6 rats). NPs were given to the rats with a doses (5, 50 mg/kg b.w./day) via oral gavage and a control group (received only 200 μl PBS). The treatment was continued for 14 days. Rats were killed with high doses of anesthesia after 14 days and dissected carefully using sterile equipment. Liver tissues were collected from all the group of rats and stored at −80 °C until further use. Homogenization of the liver was done in homogenization buffer (1:10, w/v) containing 100 mM potassium buffer (pH 7.4), 100 mM KCl and 1 mM EDTA for 90 s and then homogenates were centrifuged at 10,000 g for 30 min (+4 °C) to obtain supernatants. The supernatants of liver tissues of rats were used to analyze for glutathione levels [9], Catalase [10], superoxide dismutase (SOD) [11], the extent of lipid peroxidation (Malondialdehyde, MDA) by measuring the thiobarbituric acid reactive substances (TBARS) [12]. One-way analysis of variance (ANOVA) and Dennett test were used for statistical evaluation of results and p < 0.05 was considered as statistically significant.

Results

No mortality was found with oral administration of CuO nanoparticles for 14 days. The antioxidant enzyme levels in rat liver following exposure of NPs are presented in Fig. 1. Oral administration of NPs (with 5, 50 mg/kg b.w) to rats caused significant (P < 0.05) alterations in antioxidant enzyme activities. It was found the significant dose dependent decrease (p < 0.05) in GSH, Catalase (CAT) and SOD activity, whereas the lipid peroxidation product (MDA) levels were increased (p < 0.05). Statistically significant reduction in reduced glutathione, catalase and SOD activity represents the reduction of antioxidant enzyme levels following exposure of CuO nanoparticles and significant increase in lipid peroxidation levels indicate the tissue damage and oxidative stress. These above results confirm the liver toxicity and induction of oxidative stress by CuO nanoparticles in rat livers following their exposure for 14 days.
Fig. 1

GSH, MDA, SOD and CAT levels in liver homogenate of rats exposed to CuO NP.

P < 0.05, p < 0.01 vs control.

GSH, MDA, SOD and CAT levels in liver homogenate of rats exposed to CuO NP. P < 0.05, p < 0.01 vs control.

Discussion

Present study results clearly showed that oral exposure of CuO NP to rats for 14 days causes a significant decrease in liver antioxidant enzyme activity i.e. decrease in glutathione, SOD and Catalase levels, whereas the marker for oxidative stress i.e MDA levels (Fig. 1) were significantly increased indicating the induction of oxidative stress, which causes toxicity to the liver. These results were supported by our previous reports [[13], [14], [15]]. Moreover, our results are consistent with previous results suggesting that toxicity of CuO NPs mediated through ROS generation and oxidative stress [[16], [17], [18]]. It was reported that CuO nanoparticles induced dose dependent toxicity and oxidative stress in rats by generation of Reactive Oxygen Species (ROS) by lowering the antioxidants SOD and Catalase levels. Thus, it was confirmed that CuO nanoparticles induces toxicity and oxidative stress both in vivo as well as in vitro. Recently, Assadian et al., [8] also reported the in vitro cytotoxicity of CuO-NP, which was associated with significant increase at intracellular ROS level with effective induction of oxidative stress. The capability of NP to produce free radicals is one of the primary mechanisms of NPs toxicity [[19], [20], [21]]. It may result in oxidative stress, inflammation, and consequent damage to proteins, membranes, and DNA [22,23]. In conclusion, oral exposure of CuO nanoparticles to rats causes significant toxicity to the liver and it might be due to oxidative stress. More extensive studies would be needed to verify the safety issues related to increased usage of CuO NPs by consumers.

Conflict of interest

No conflicts of interest.
  18 in total

1.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

Review 2.  Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.

Authors:  Xiaopin Duan; Yaping Li
Journal:  Small       Date:  2012-09-28       Impact factor: 13.281

3.  Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.

Authors:  G Oberdörster
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

Review 4.  Photochemical transformations on plasmonic metal nanoparticles.

Authors:  Suljo Linic; Umar Aslam; Calvin Boerigter; Matthew Morabito
Journal:  Nat Mater       Date:  2015-06       Impact factor: 43.841

5.  Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells.

Authors:  Anreddy Rama Narsimha Reddy; Yellu Narsimha Reddy; Devarakonda Rama Krishna; Vurimindi Himabindu
Journal:  Toxicology       Date:  2010-04-03       Impact factor: 4.221

6.  Toxicity of Copper Oxide (CuO) Nanoparticles on Human Blood Lymphocytes.

Authors:  Evelyn Assadian; Mohammad Hadi Zarei; Ali Ghanadzadeh Gilani; Mehrzad Farshin; Hamid Degampanah; Jalal Pourahmad
Journal:  Biol Trace Elem Res       Date:  2017-10-24       Impact factor: 3.738

7.  In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles.

Authors:  Xiaoke Hu; Sean Cook; Peng Wang; Huey-Min Hwang
Journal:  Sci Total Environ       Date:  2009-02-12       Impact factor: 7.963

8.  Nanosized zinc oxide particles induce neural stem cell apoptosis.

Authors:  Xiaoyong Deng; Qixia Luan; Wenting Chen; Yanli Wang; Minghong Wu; Haijiao Zhang; Zheng Jiao
Journal:  Nanotechnology       Date:  2009-02-24       Impact factor: 3.874

9.  Effects of sub-acute exposure to TiO2, ZnO and Al2O3 nanoparticles on oxidative stress and histological changes in mouse liver and brain.

Authors:  Rupal Shrivastava; Saimah Raza; Abhishek Yadav; Pramod Kushwaha; Swaran J S Flora
Journal:  Drug Chem Toxicol       Date:  2013-12-17       Impact factor: 3.356

10.  Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition.

Authors:  Hui Yang; Chao Liu; Danfeng Yang; Huashan Zhang; Zhuge Xi
Journal:  J Appl Toxicol       Date:  2009-01       Impact factor: 3.446

View more
  5 in total

1.  Effect of Copper Nanoparticles in the Diet of WKY and SHR Rats on the Redox Profile and Histology of the Heart, Liver, Kidney, and Small Intestine.

Authors:  Ewelina Cholewińska; Jerzy Juśkiewicz; Michał Majewski; Radosław Smagieł; Piotr Listos; Bartosz Fotschki; Irena Godycka-Kłos; Katarzyna Ognik
Journal:  Antioxidants (Basel)       Date:  2022-05-06

2.  Pulmonary Exposure to Copper Oxide Nanoparticles Leads to Neurotoxicity via Oxidative Damage and Mitochondrial Dysfunction.

Authors:  Hongmei Zhou; Ling Yao; Xuejun Jiang; Golamaully Sumayyah; Baijie Tu; Shuqun Cheng; Xia Qin; Jun Zhang; Zhen Zou; Chengzhi Chen
Journal:  Neurotox Res       Date:  2021-04-07       Impact factor: 3.911

3.  Copper Oxide Nanoparticles Stimulate the Immune Response and Decrease Antioxidant Defense in Mice After Six-Week Inhalation.

Authors:  Jana Tulinska; Miroslava Lehotska Mikusova; Aurelia Liskova; Milena Busova; Vlasta Masanova; Iveta Uhnakova; Eva Rollerova; Radka Alacova; Zora Krivosikova; Ladislava Wsolova; Maria Dusinska; Mira Horvathova; Michaela Szabova; Norbert Lukan; Martina Stuchlikova; Daniel Kuba; Zbynek Vecera; Pavel Coufalik; Kamil Krumal; Lukas Alexa; Lucie Vrlikova; Marcela Buchtova; Jana Dumkova; Pavel Piler; Vojtech Thon; Pavel Mikuska
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

4.  Magneto-optical hyperthermia agents based on probiotic bacteria loaded with magnetic and gold nanoparticles.

Authors:  Víctor Garcés; Ana González; Natividad Gálvez; José M Delgado-López; Jose J Calvino; Susana Trasobares; Yilian Fernández-Afonso; Lucía Gutiérrez; José M Dominguez-Vera
Journal:  Nanoscale       Date:  2022-04-14       Impact factor: 7.790

5.  Microwave induced synthesis of ZnO nanorods and their efficacy as a drug carrier with profound anticancer and antibacterial properties.

Authors:  Pritam Sadhukhan; Mousumi Kundu; Shallu Rana; Raj Kumar; Joydeep Das; Parames C Sil
Journal:  Toxicol Rep       Date:  2019-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.